Laboratory confirmation of buruli ulcer disease in togo, 2007-2010

PLoS Neglected Tropical Diseases

Volumn 5, Issue 7, 2011, Pages

  Bretzel, Gisela ^a   Huber, Kristina Lydia ^a   Kobara, Basil ^e   Beissner, Marcus ^a   Piten, Ebekalisai ^c   Herbinger, Karl Heinz ^a   Wiedemann, Franz Xaver ^b   Amekuse, Komi ^b   Kere, Abiba ^d   Helfrich, Kerstin ^a   Fleischmann, Erna ^a   Löscher, Thomas ^a   Diefenhardt, Adolf ^b   Nitschke, Jörg ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum der Ludwig Maximilians Universität München   (Togo)

^c Centre Hospitalier Régionale Tsévié CHR   (Togo)

^d National Institute of Hygiene INH   (Togo)

^e Programme National de Lutte Contre l'Ulcère de Buruli la Lèpre et le Pian PNLUB LP   (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BURULI ULCER; CASE FINDING; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; QUALITY CONTROL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TOGO; TREND STUDY; CHI SQUARE DISTRIBUTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM ULCERANS; PREVALENCE; TROPICAL MEDICINE;

ADOLESCENT; AGED; BURULI ULCER; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MIDDLE AGED; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDIES; TOGO; TROPICAL MEDICINE;

EID: 79960946484     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001228     Document Type: Article

References (30)

1. WHO (2008) Buruli ulcer: progress report, 2004-2008. Weekly epidemiological record 17: 145-154.
2. Ellen DE, Stienstra Y, Teelken MA, Dijkstra PU, van der Graaf WT, et al. (2003) Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Trop Med Int Health 8: 90-96.
3. Phanzu DM, Bafende EA, Dunda BK, Imposo DB, Kibadi AK, et al. (2006) Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg 75: 311-314.
4. WHO (2006) Buruli Ulcer: Prevention of Disability (POD). World Health Organization, Geneva, Switzerland.
5. Schunk M, Thompson W, Klutse E, Nitschke J, Opare-Asamoah K, et al. (2009) Outcome of patients with buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana. Am J Trop Med Hyg 81: 75-81.
6. WHO (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization, Geneva, Switzerland.
7. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186.
8. Chauty A, Ardant MF, Adeye A, Euverte H, Guedenon A, et al. (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51: 4029-4035.
9. Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, et al. (2010) Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375: 664-672.
10. WHO (2007) Summary report of the WHO annual meeting on Buruli ulcer, 2-4 April 2007 and Report of the Technical Advisory Group (TAG) meeting, 5 April 2007. World Health Organization, Geneva, Switzerland. Accessible via http://www.who.int/buruli/events/Report_2007_meeting_FINAL.pdf.
11. WHO (2008) Meeting of the WHO Technical Advisory Group on Buruli ulcer 3 April, 2008. World Health Organization, Geneva, Switzerland. Accessible via http://www.who.int/buruli/events/TAG_report_FINAL.pdf.
12. Johnson PD, Hayman JA, Quek TY, Fyfe JA, Jenkin GA, et al. (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186: 64-68.
13. Herbinger KH, Adjei O, Awua-Boateng NY, Nienhuis WA, Kunaa L, et al. (2009) Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48: 1055-1064.
14. Beissner M, Herbinger KH, Bretzel G, (2010) Laboratory diagnosis of Buruli ulcer disease. Future Microbiol 5: 363-370.
15. Meyers WM, Tignokpa N, Priuli GB, Portaels F, (1996) Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. Br J Dermatol 134: 1116-1121.
16. Songné B, Abete B, Scotte M, Tignokpa N, Valenti P, (2001) [Buruli ulcer in Togo: 21 cases]. Presse Med 30: 533.
17. James K, Attipou KK, James YE, Blakime M, Tignokpa N, et al. (2003) [Buruli ulcer in Togo: a hospital study]. Sante 13: 43-47.
18. WHO (2009) Buruli ulcer: first programme review meeting for West Africa- summary report. Wkly Epidemiol Rec 84: 43-48.
19. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson R, et al. (2006) External quality assurance for the laboratory diagnosis of Buruli ulcer disease in Ghana. Trop Med Int Health 11: 1688-1693.
20. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, et al. (2007) A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 12: 89-96.
21. Siegmund V, Adjei O, Nitschke J, Thompson W, Klutse E, et al. (2007) Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease. Clin Infect Dis 45: 68-75.
22. Herbinger KH, Beissner M, Huber K, Awua-Boateng NY, Nitschke J, et al. (2010) Efficiency of Fine Needle Aspiration Compared with other Sampling Techniques for the Laboratory Diagnosis of Buruli Ulcer Disease. J Clin Microbiol 48: 3732-3734.
23. WHO (2001) Diagnosis of Mycobacterium ulcerans disease. World Health Organization, Geneva, Switzerland.
24. Ross BC, Marino L, Oppendisano F, Edwards R, Robins-Browne RM, et al. (1997) Development of a PCR Assay for rapid Diagnosis of Mycobacterium ulcerans Infection. J Microbiol Clin 35 (7): 1696-700.
25. Stinear T, Ross BC, Davies JK, Marino L, Robins-Browne RM, et al. (1999) Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 37: 1018-1023.
26. Siegmund V, Adjei O, Racz P, Berberich C, Klutse E, et al. (2005) Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic. J Clin Microbiol 43: 271-276.
27. Phillips RO, Sarfo FS, Osei-Sarpong F, Boateng A, Tetteh I, et al. (2009) Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol 47: 924-926.
28. Eddyani M, Fraga AG, Schmitt F, Uwizeye C, Fissette K, et al. (2009) Fine needle aspiration, an efficient sampling technique for the bacteriological diagnosis of nonulcerative Buruli ulcer lesions. J Clin Microbiol 47: 1700-1704.
29. Cassisa V, Chauty A, Marion E, Ardant MF, Eyangoh S, et al. (2010) Use of fine-needle aspiration for diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 48: 2263-2264.
30. WHO (2010) Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease). World Health Organization, Geneva, Switzerland.